Home · Peptides · Stamakort
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Stamakort

THE STOMACH PROTECTOR

A-10 Gastric Mucosa Bioregulator Peptide

Stamakort is a gastric-mucosa-derived peptide bioregulator that helps restore stomach lining health. It promotes mucus and bicarbonate secretion, enhances blood flow to the stomach lining, and reduces inflammation. It's used for gastritis, ulcers, and general digestive vulnerability. It helps your stomach rebuild its protective barrier.

Stamakort
Stamakort
Stamakort

Stamakort Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Stamakort

◆

Is Stamakort FDA approved?

No. This profile records Stamakort as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Stamakort?

Dose: 30 mg orally each morning.

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Stamakort guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Mucus Production

Increases protective mucus layer (MUC5AC)

Bicarbonate Secretion

Enhances acid-neutralizing secretions

Anti-Inflammatory

Suppresses NF-κB and inflammatory cytokines

VEGF Stimulation

Promotes blood flow to stomach lining

Those with chronic gastritis
People prone to stomach ulcers
Anyone with acid reflux issues
Those taking NSAIDs regularly
People wanting to protect digestive health

Stamakort Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.